Zhitong Finance App News, Tong Ren Tang Technology (01666) issued an announcement. The company's subsidiary, Beijing Tong Ren Tang Sinopharm Co., Ltd. (Tong Ren Tang), has received the “Certificate of Registration for Proprietary Chinese Medicine” issued by the Hong Kong Traditional Chinese Medicine Administration to allow the sale of “Three Child Care Granules [Tong Ren Tang]” in Hong Kong Special Administrative Region of China.

The function of “Three Child Care Granules [Tongrentang]” is to warm the lungs and relieve phlegm, lower gas and digestion. It is used for symptoms of phlegm congestion, wheezing, excessive phlegm, chest pain, poor diet, white tongue, and smooth pulse. As of the date of this announcement, the Group has invested a total of approximately HK$800,000 in R&D of the “Three Child Care Pellets [Tong Ren Tang]” (the amount has not been audited), and the product has not yet been put on the market.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.